bioAffinity Technologies, Inc. (BIAF) KPIs and segments
Close on Nov 18, 2026Market cap $17.42MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive bioAffinity Technologies's business
bioAffinity Technologies's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Laboratory Services($M) | 1.51 | 1.35 | 1.59 | 1.45 | 1.27 | 1.85 | 2.21 | 2.35 | 2.39 | 2.40 | 2.21 | 0.28 | |
Health Care, Patient Service($M) | 1.24 | 1.08 | 1.29 | 1.17 | 0.94 | 1.57 | 1.92 | 2.05 | 2.06 | 2.15 | 1.95 | ||
Histology Service Fees($M) | 0.25 | 0.25 | 0.29 | 0.26 | 0.31 | 0.26 | 0.29 | 0.28 | 0.29 | 0.24 | 0.24 | ||
Medical Director Fees($M) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |||
Other Revenues($M) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.02 | 0.00 | 0.00 | |||
Diagnostic R&D($M) | 0 | 0.00 | 0 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |||||
Department of Defense Observational Studies($M) | 0 | 0.00 | 0 | 0.00 | 0.00 | 0.00 | 0.01 | ||||||
Earlier reporting (last reported 2024)5 | |||||||||||||
Diagnostic R&D($M) | -0.84 | -0.68 | -0.44 | -0.51 | -0.52 | -0.37 | -0.45 | -0.44 | -0.53 | -0.44 | |||
Laboratory Services($M) | -1.79 | -1.83 | -1.65 | -2.27 | -2.52 | -2.15 | -2.54 | -2.74 | -3.46 | -0.31 | |||
General Corporate Activities($M) | -2.22 | -2.45 | -1.70 | -1.71 | -2.11 | -1.81 | -1.50 | -1.17 | -0.57 | -1.85 | |||
3 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-07.
See a number that looks wrong?